The Harvard Medical School Fellowship Program in Transfusion Medicine (TM) is an ACGME-accredited program which draws on the facilities of Mass General, Brigham and Women’s Hospital (BWH), Children’s Hospital Boston (CHB), and Dana-Farber Cancer Institute (DFCI).
In addition, the program maintains strong ties with the Center for Hematology. The usual period of clinical fellowship is one year; however, the program offers suitably qualified fellows the opportunity to pursue research relevant to transfusion medicine supported by a NIH training grant for an additional one or two years.
Effective with the fellows entering in July 2025, trainees will spend six months on the transfusion service, typically with three months at Mass General and three months at the Longwood campus comprising BWH, CHB, and DFCI. They will spend two months in trainee-selected clinical electives, such as pediatric TM, cellular therapies, hemophilia/coag, etc. The remaining three months are spent in elective rotations, typically with a focus on research or other academic projects, which are chosen once the trainee has received a thorough grounding in transfusion medicine and begun to formulate specific career goals. There are 4 weeks of vacation during the year.
Clinical and basic research are conducted throughout the program. Fellows are encouraged to develop a research focus during their ACGME base year which can be pursued for an additional one or two years, if there is a vacancy on the NIH training grant. Fellows have the opportunity to attend varied clinical and research conferences and are required to teach in the training programs offered to residents, students and post-graduates.
There are four funded clinical fellowship positions and eight funded research fellowship positions.
The combined facilities of the Harvard Joint Program comprise 2,478 hospital beds supporting a comprehensive array of general and specialized services including transplantation, Level I Pediatric and Adult Trauma and Burn Units, multiple intensive care units, and centers for Sickle Cell Disease and Hemophilia. The facilities collect approximately 38,000 donations of whole blood and platelets and transfuse approximately 190,000 components annually. The combined facilities of the Harvard Joint Program offer an unparalleled array of services, which encompass all aspects of Transfusion Medicine.
Applicants must be Board-certified or eligible for certification in Clinical Pathology, adult or pediatric Hematology/Oncology, Internal Medicine, Obstetrics/Gynecology, Surgery, or Anesthesia and, if a graduate of an international medical school, have a valid ECFMG certificate and visa and a full Massachusetts medical license prior to starting the fellowship.
Applications should be submitted by December 31 of each year (18 months prior to start date; Fellowships usually commence on July 1).
Please send the following materials to express your interest to: MGBTMFellowshipInquiries@mgb.org
Brigham and Women's Hospital
Massachusetts General Hospital
Beth Israel-Deaconess Medical Center
Children's Hospital, Boston
Dana-Farber Cancer Institute
Patricia Brunker, Fellowship Director
Carrie Racsumberger, Program Manager, cracsumberger@mgb.org
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.
About BWH